IMERYS (EPA:NK) - Number of outstanding shares and voting rights as of January 31,2020
Transparency directive : regulatory news
25/02/2020 07:35
Click here to download pdf version
INFORMATION
24 February 2020
Number of outstanding shares and voting rights as of 31 January 2020
published pursuant to the provisions of article L. 233-8-II of the French Code
de Commerce and articles 221-1 et seq. and 223-16 of the AMF's General
Regulations
31 January 2020
Total number of outstanding shares 79,500,457
Total number of theoretical voting rights determined
on all the shares making up the share capital,
including those without voting rights (*) 126,810,220
Total number of net voting rights 126,226,961
(*) Treasury shares
The world leader in mineral-based specialty solutions for industry with EUR4.4
billion in revenue and 16,300 employees in 2019. Imerys delivers high
value-added, functional solutions to a great number of sectors, from processing
industries to consumer goods. The Group draws on its understanding of
applications, technological knowledge and expertise in material science to
deliver solutions by beneficiating its mineral resources, synthetic minerals
and formulations. Imerys' solutions contribute essential properties to
customers' products and their performance, including heat resistance, hardness,
conductivity, opacity, durability, purity, lightness, filtration, absorption
and water repellency. Imerys is determined to develop responsibly, in
particular by fostering the emergence of environmentally-friendly products and
processes.
More comprehensive information about Imerys may be obtained from its website
(www.imerys.com) under Regulated Information, particularly in its Registration
Document filed with Autorité des marchés financiers on March 20, 2019 under
number D.19-0175 (also available from the Autorité des marchés financiers
website, www.amf-france.org). Imerys draws the attention of investors to
chapter 4, "Risk Factors and Internal Control" of its Registration Document.
Disclaimer: This document contains projections and other forward-looking
statements. Investors should be aware that such projections and forward-looking
statements are subject to various risks and uncertainties (many of which are
diffcult to predict and generally beyond the control of Imerys) that could
cause actual results and developments to differ materially from those expressed
or implied
Investor Relations Press Contact
Vincent Gouley + 33 (0)1 49 55 64 69
finance@imerys.com Claire Garnier +33 (0)1 4955 6427